Abstract Objectives: To observe the clinical features and angiographic findings in patients with a spontaneous isolated superior mesenteric artery dissection (SISMAD) and to identify any correlation between them. Methods: From a single institution, 32 patients (22 symptomatic patients at presentation; mean age 54 years; men 97%) with SISMAD were retrospectively reviewed. All patients were available for clinical follow-up after treatment (conservative, n Z 28, 88%, open or endovascular superior mesenteric artery (SMA) reconstruction, n Z 4, 12%), and follow-up CT scans were available in 28 patients (mean 22 months, range 1e80 months). Results: We found a positive correlation between pain severity and dissection length (p Z 0.03, r Z 0.50, Spearman's partial correlation analysis). After conservative treatment, only one patient (3%) required bowel resection, and there was no difference in outcome between patients who were treated with anticoagulation or anti-platelet therapy and those who were not (p Z 1.00, Fisher's exact test). No patients had progression of their lesion on the follow-up CT angiography. Conclusions: In SISMAD patients, dissection length is positively associated with more severe clinical symptoms. After conservative treatment, we observed a benign clinical course and no CT progression of the dissection, even without anticoagulation or anti-platelet therapy. Based on our observation, patients with SISMAD can be treated conservatively without anticoagulation therapy. ª
Introduction
Spontaneous isolated superior mesenteric artery dissection (SISMAD) has been anecdotally reported as a rare cause of acute abdominal pain. 1e13 The increasing use of diagnostic imaging studies in the management of patients with acute abdominal pain has resulted in SISMAD being more recognised in recent times. Although a few case series have described the clinical course of SISMAD, 14, 15 the natural course and optimal management of this rare disease have not yet been firmly established.
Currently, spiral CT scan is the diagnostic test of choice in patients suspected of SISMAD and the most commonly used test when SISMAD is diagnosed incidentally. When discovered, the treatment options for SISMAD have been less uniform and range from conservative therapy 6, 7, 13, 15 to endovascular 1, 5 or open surgical treatment.
2e4, 8, 9, 11, 16 Additionally, with conservative treatment, there is no consensus on the benefit of anti-thrombotic therapy. Some patients need early aggressive treatment for SISMAD based on their presentation. In this study, we attempted to identify those patients who might benefit from intervention. Specifically, we sought a correlation between abdominal pain and CT angiogram findings, looking for specific angiographic findings that indicated the need for initial invasive treatment. These findings were also correlated with clinical outcome.
Materials and Methods
During the 7-year period from July 2001 to June 2008, 32 patients with SISMAD were detected at a single tertiary care university hospital. Of these, 19 patients were diagnosed at our institution and 13 patients were referred from outside hospitals. SISMAD was diagnosed by the presence of the characteristic superior mesenteric artery (SMA) wall dissection on abdominal spiral CT angiography (Fig. 1) . Patients with concomitant aortic dissection or a recent history of blunt abdominal trauma (n Z 1) or those who had undergone SMA catheterisation (n Z 1) or recent upper abdominal surgery were excluded from this study. We prospectively followed up the clinical features of these patients and the follow-up CT images in the latter 25 patients and retrospectively reviewed the medical recordings and imaging in seven patients who were diagnosed earlier during the study period. The recorded clinical features include the nature of abdominal pain (onset, duration, severity and relation to meals) and the provoking event (overeating, overdrinking and pancreatitis). Severity of abdominal pain at initial presentation was graded 0e10 using a visual analogue scale. The initial CT angiogram was assessed for entry and re-entry points of the dissection, dissection length, patency and degree of luminal stenosis at the dissected segment of the SMA. To assess angiographic features, both axial and reconstructed sagittal views of contrast-enhanced spiral CT scans were independently interpreted by two experienced attending radiologists. Angiographic findings were categorised into three types according to the presence of false luminal flow and true lumen patency at the dissected segment (Table 1, Fig. 2 ). Dissection entry sites were categorised into three zones, namely: Zone 1, orifice to 1 cm proximal to the SMA curvature; Zone 2, from 1 cm proximal to 1 cm distal to the SMA curvature; and Zone 3, distal to 1 cm distal to the SMA curvature. Conservative treatment consisted of bowel rest, nasogastric suction, intravenous fluid therapy and parenteral nutritional support as required. During the earlier part of this study, we used intravenous anticoagulation therapy in five patients, but all subsequent patients received neither anticoagulation nor anti-platelet therapy. Surgical or endovascular interventions were performed for suspected bowel infarction or severe, persistent abdominal pain (n Z 4) despite maximal conservative treatment. All patients were followed up on an outpatient basis (mean 26 months; range 1e80 months). During follow-up, abdominal symptoms (recurrent or residual) were assessed. CT angiograms were performed every 6 months to look for evolution of SISMAD. Of the 32 patients, 28 (88%) were available for follow-up with CT angiogram (mean 22 months; range 1e80 months). 
Results
The demographic and clinical features of the 32 patients are shown in Table 2 . Twenty-two (69%) patients presented with abdominal pain, whereas 10 patients were asymptomatic and had their SISMAD discovered incidentally. In these patients, there was no other abdominal symptom attributable to SISMAD.
At presentation, SISMAD lesions were categorised into the following groups according to their angiographic findings: 41% Type I, 50% Type II and 9% Type III. The Type I lesions were most common in incidentally discovered patients (seven of 10, 70%), whereas Type II lesions were the most common type in symptomatic patients (13 of 22, 59%). With regards to dissection entry site, Zone 2 (SMA segment from 1 cm proximal to 1 cm distal to the SMA curvature) was the most common site of entry (22 of 32, 69%).
The median length of dissection was longer in the symptomatic patients than in the incidentally detected patients (64 mm, range 20e160 mm vs. 35 mm, range 23e 78 mm, p Z 0.04, by ManneWhitney test). When entry site locations were categorised into three zones, no differences were detected between symptomatic and incidentally detected patients (p Z 0.16 by Fisher's exact test). In the 22 symptomatic patients, pain severity scores showed a positive correlation with SISMAD length (p Z 0.03 and r Z 0.50 by Spearman's partial correlation analysis, Fig. 3 ), but not with angiographic type (p Z 0.07 by Spearman's partial correlation analysis).
Twenty-eight patients (including 10 asymptomatic patients) underwent conservative treatment. In four patients with severe and persistent abdominal pain, we restored SMA flow as follows: two retrograde aortomesenteric bypasses, one SMA thrombo-intimectomy with patch closure and one SMA stenting (4 Â 40 mm selfexpandable nitinol stent). None of those patients had bowel gangrene at operation. Table 3 demonstrates the follow-up results of the 32 patients. Among the patients who were treated conservatively, there was no difference in the clinical outcomes among patients who received anticoagulation (n Z 5), antiplatelet therapy (n Z 4) or treatment (n Z 19) (p Z 1.00, Fisher's exact test). Table 4 presents follow-up angiographic results for 28 SISMAD patients treated conservatively. In four patients, SISMAD healed completely, with a median time to healing of 6 months (range 3e16 months). Either anticoagulant or anti-platelet agent was given to one patient each, and two patients did not receive any antithrombic agent.
Discussion
Although spontaneous aortic dissection is a well-known and common vascular disease, spontaneous dissection of peripheral arteries is rare. Of the peripheral arteries, the SMA is the second most common artery after the internal carotid artery. 5 Since Bauersfeld reported the first case of SISMAD in 1947, 17 treatment results for SISMAD patients have been disparate. To our knowledge, the present report constitutes the largest series of patients with SISMAD from a single institution. Due to the rarity of this disease, the underlying cause and the natural course of SISMAD have yet to be determined.
In contrast to the well-known correlation between hypertension and aortic dissection, 18 hypertension was only present in a third of our patient group. To explain the underlying mechanism of SISMAD, Solis et al. 16 focussed on the location of the entry point of dissection, which is usually located at 1.5e3 cm distal to the orifice of SMA. This segment of the SMA is a transition zone of the SMA from a fixed segment under the pancreas to the mobile segment at the mesenteric root. This transition point could be the focus of intimal tear due to abnormal sheering stress. Subsequent to finding that all SISMAD entry points were a Progression on the follow-up spiral CT angiography. b SMA stent was occluded at 17 months after insertion but the patient was free from bowel ischemic symptom for 31 months.
c Three patients with recurrent symptom include two patients with postprandial abdominal discomfort and one patient requiring segmental resection of ileum due to bowel stricture. located near the curvature of the SMA, we hypothesised that the convex-curved run of the SMA might provide an additional mechanical factor that initiates SMA dissection.
Recently, Hashimoto et al. 19 reported a case of acute SMA dissection in a patient who had pathologically proven segmental arterial mediolysis. There is a changing trend in treatment of SISMAD from open surgical treatment 2e4, 8, 9, 11, 16 which was favoured in earlier days over SMA stenting 1, 5 or conservative treatment. 6, 7, 12, 13, 15 Previous recommendation for treatment of SISMAD was based on experiences with a limited number of patients and short-term follow-up.
Various surgical techniques have been described for treatment of SISMAD, including aorto-mesenteric bypass, 2, 3 thrombo-intimectomy with optional patch angioplasty, 2, 4, 16 endo-aneurysmorrhaphy, 2,9 SMA interposition 8 and right gastro-epiploic artery-to-SMA bypass. 11 In the early part of this study, we performed two aorto-SMA bypasses and one SMA thrombo-intimectomy for patients having persistent abdominal pain. Given the limitations of a retrospective review, the need for open surgery cannot be justified.
Some authors have reported stent placement in the SMA for SISMAD treatment, 1, 5 and concluded that this modality is a safe and feasible therapeutic option, but its long-term results have yet to be determined. In our series, one patient underwent stent placement which was found to be occluded at 17 months; however, the patient remained free from ischaemic bowel symptom at 31 months follow-up.
Recently, favourable outcomes have been reported by many authors following conservative treatment. Considering pain severity as a key factor in the decisionmaking algorithm in terms of determining the need for intervention in patients with an acute abdomen, we attempted to identify any correlation between pain severity and arteriographic type of SISMAD. Sakamoto et al. 15 categorised SISMAD into four types based on imaging appearances. They did not include total thrombotic occlusion of SMA trunk in their classification. Total thrombotic occlusion due to SISMAD can be missed if incorrectly identified as SMA thrombosis. In the present study, SMA dissection as an underlying cause of total occlusion of the SMA trunk was detected by reviewing prior imaging studies (contrast abdominal CT scan) performed at other institutions before the patient was referred to us. In our study, there was no correlation between arteriographic type and pain severity; however, there was a positive correlation between pain severity and dissection length even though the correlation is weak. Some authors describe an inflammatory response around the arterial dissection, which stimulates the visceral nerve plexus, thus inducing pain. 20 It seems logical that longer dissections would cause more inflammation, and thus pain.
To determine whether abdominal pain could be attributed to bowel ischaemia, we investigated the frequency of postprandial pain. This was present in only 27% of the 22 symptomatic patients. Moreover, in the majority of patients, pain subsided spontaneously after a mean duration of 3.5 days of conservative treatment. From these observations, we believe that most abdominal pain in SISMAD patients was not derived from bowel ischaemia.
In terms of anticoagulation therapy in SISMAD, some authors have advocated its use 6, 7 to prevent thrombus propagation, while others have not. 12, 14 The argument for anticoagulation therapy is based on early case reports before the 1970s in which SISMAD patients developed bowel necrosis when treated conservatively without anticoagulation therapy. However, there has been no firm evidence to support anticoagulation therapy in SISMAD. In patients with spontaneous dissection of the carotid artery, anticoagulation has usually been prescribed to prevent secondary thrombosis of distal intracranial arterial bed.
Anticoagulation can prevent false lumen thrombosis at the dissected SMA, and thus promote further propagation of dissection. During the early period of this study, we routinely used anticoagulant therapy, but discontinued its use when we noticed that patients referred from other hospitals without anticoagulation therapy had no difference in their clinical outcomes. Furthermore, we did not appreciate a difference in outcome with use of anticoagulants or anti-platelet agents for SISMAD patients.
During follow-up, no patient had lesion progression on spiral CT scans, except for one who had mild dilatation of SMA at the anastomosis site between polytetrafluoroethylene (PTFE) graft and thrombo-intimectomised SMA.
Recently, Takayama et al. 14 reported their series of isolated spontaneous dissection of the splanchnic arteries including 11 SISMAD. According to their observation, they also found no expansion or progression of the false lumen after follow-up of 21 months (2e116 months). We found that recurrent abdominal symptoms developed in four (18%) patients who initially presented with pain, but no late pain developed in 10 patients who were incidentally detected. a Twenty-eight patients who underwent conservative treatment were included.
b Type of SISMAD: Type I, patent true and false lumen revealing entry and re-entry sites; Type II, patent true lumen but no flow through the false lumen; Type III, SMA dissection with SMA occlusion.
c Location of entry site: Zone 1, SMA segment from the orifice to 1 cm proximal to the SMA curvature; Zone 2, SMA segment from 1 cm proximal to 1 cm distal to the SMA curvature; Zone 3, distal to Zone 2.
